Follow the money
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We shall see. I'm not going anywhere. Notes consolidated right before the peer review news. I smell a major run coming.
$CELZ new October 2019 Shareholder Update: We Promised, We Delivered
Creative Medical Technology Holdings, Inc. Logo (PRNewsfoto/Creative Medical Technology Hol)
NEWS PROVIDED BY
Creative Medical Technology Holdings, Inc.
Oct 10, 2019, 08:15 ET
PHOENIX, Oct. 10, 2019 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading commercial stage biotechnology company focused on Urology, Neurology and Orthopedics using stem cell treatments, today provided shareholder updates.
"The third quarter of 2019 was one of the most productive in our company's history," said Donald Dickerson, CFO of Creative Medical Technology Holdings Inc. "We laid out a roadmap for the back half of the year, and I am proud that we have delivered on all fronts."
October 2019 Shareholder Update
October 2019 Shareholder Update
"I am thrilled with the effort of our team and am confident the fruit of their labor will come to the
forefront as we close out the year," commented Timothy Warbington, President and CEO of Creative Medical Technology Holdings, Inc. "I would also like to take a moment to thank our committed shareholders, as we recognize the stock price has not been reflective of the intrinsic value we have built in the company. Please rest assured we remain committed to increasing shareholder value, and believe your patience will be greatly rewarded in the near future."
$CELZ news October 2019 Shareholder Update: We Promised, We Delivered
Creative Medical Technology Holdings, Inc. Logo (PRNewsfoto/Creative Medical Technology Hol)
NEWS PROVIDED BY
Creative Medical Technology Holdings, Inc.
Oct 10, 2019, 08:15 ET
PHOENIX, Oct. 10, 2019 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading commercial stage biotechnology company focused on Urology, Neurology and Orthopedics using stem cell treatments, today provided shareholder updates.
"The third quarter of 2019 was one of the most productive in our company's history," said Donald Dickerson, CFO of Creative Medical Technology Holdings Inc. "We laid out a roadmap for the back half of the year, and I am proud that we have delivered on all fronts."
October 2019 Shareholder Update
October 2019 Shareholder Update
"I am thrilled with the effort of our team and am confident the fruit of their labor will come to the
forefront as we close out the year," commented Timothy Warbington, President and CEO of Creative Medical Technology Holdings, Inc. "I would also like to take a moment to thank our committed shareholders, as we recognize the stock price has not been reflective of the intrinsic value we have built in the company. Please rest assured we remain committed to increasing shareholder value, and believe your patience will be greatly rewarded in the near future."
$CELZ news October 2019 Shareholder Update: We Promised, We Delivered
Creative Medical Technology Holdings, Inc. Logo (PRNewsfoto/Creative Medical Technology Hol)
NEWS PROVIDED BY
Creative Medical Technology Holdings, Inc.
Oct 10, 2019, 08:15 ET
PHOENIX, Oct. 10, 2019 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading commercial stage biotechnology company focused on Urology, Neurology and Orthopedics using stem cell treatments, today provided shareholder updates.
"The third quarter of 2019 was one of the most productive in our company's history," said Donald Dickerson, CFO of Creative Medical Technology Holdings Inc. "We laid out a roadmap for the back half of the year, and I am proud that we have delivered on all fronts."
October 2019 Shareholder Update
October 2019 Shareholder Update
"I am thrilled with the effort of our team and am confident the fruit of their labor will come to the
forefront as we close out the year," commented Timothy Warbington, President and CEO of Creative Medical Technology Holdings, Inc. "I would also like to take a moment to thank our committed shareholders, as we recognize the stock price has not been reflective of the intrinsic value we have built in the company. Please rest assured we remain committed to increasing shareholder value, and believe your patience will be greatly rewarded in the near future."
$CELZ
14+ patents & applications + 4 trademarks w
2 Patented cell therapies
(@CaverStem @femcelz)
Revs 112,400 ?? 681%
Global expansion
StemSpine — late 2019
Insiders own 110M commons
BUYOUT candidate
$CELZ
14+ patents & applications + 4 trademarks w
2 Patented cell therapies
(@CaverStem @femcelz)
Revs 112,400 ?? 681%
Global expansion
StemSpine — late 2019
Insiders own 110M commons
BUYOUT candidate
$CELZ
14+ patents & applications + 4 trademarks w
2 Patented cell therapies
(@CaverStem @femcelz)
Revs 112,400 ?? 681%
Global expansion
StemSpine — late 2019
Insiders own 110M commons
BUYOUT
Load me up some .0005's plz
Shareholders you are going to love your
.0006's & .0007's by the end of the week into the next $LIBE
Not missing the buying opportunity. Opportunity knocks answer! $LIBE
Added $LIBE .0006
No brainer
100M in revenue to grow to 300M by next year
What am I missing. Oh reverse split not happening for some time.
Even if it happens going to fly post reverse imo
MEGA MERGER IN THE OTC
Don't miss your 2nd chance for cheapies + an easy double
$CELZ
.0008
Creative Medical Technology Holdings Inc @CMTH_Inc
IP portfolio
14+ patents & applications + 4 trademarks w/
2 Patented cell therapies
(@CaverStem @femcelz)
Revs 112,400 ?? 681%
StemSpine — late 2019
Insiders & Ceo own 110M commons
$CELZ
DD
Creative Medical Technology Holdings Inc @CMTH_Inc
IP portfolio 14+ patents & applications + 4 trademarks w/
2 Patented cell therapies
(@CaverStem @femcelz)
Revs 112,400 ?? 681%
StemSpine — late 2019
Insiders & Ceo own 110M commons
BUYOUT!!
$CELZ
.0006
Creative Medical Technology Holdings Inc @CMTH_Inc
IP portfolio 14+ patents & applications + 4 trademarks w/
2 Patented cell therapies
(@CaverStem @femcelz)
Revs 112,400 ?? 681%
StemSpine — late 2019
Insiders & Ceo own 110M commons
BUYOUT!!
$CELZ #stemcells
.0006
Creative Medical Technology Holdings Inc @CMTH_Inc
IP portfolio 14+ patents & applications + 4 trademarks w/
2 Patented stemcell therapies
(@CaverStem @femcelz)
Revs 112,400 ?? 681%
StemSpine — late 2019
Insiders & Ceo own 110M commons
BUYOUT!!
I agree when MM's let it breathe a nice spike will come $CELZ
Why no reverse split
No reverse split
I'll be adding on the dip!
Not for nothing when private. They may get huge financial aid from Wallstreet bankers & list on the Nasdaq. $LAHO
Once everything is complete with new cusip name and symbol change. The merger will be finalized & repriced at a fair market value like an IPO. Could reopen at .25
I am holding for sure. Grey market trading will be interesting though.
Best to get revoked without Grey market trading imo
Would be similar to an IPO when things get ironed out. New cusip & fully reporting company. $LAHO
Check out the filings as well. https://www.sec.gov/cgi-bin/browse-edgar?company=Lans+Holdings+Inc&owner=exclude&action=getcompany
$LAHO LinkedIn profile updated 4 hours ago. Looking extremely promising
— John Guerriero (@vulken17) September 11, 2019
🤔 pic.twitter.com/Qi8EQ4vLjR
Good point. There is an exception to the rules. We shall see moving forward
What some do not understand is if the big money wants the pps higher even if they are on the Greys than that's where it will go. Money talks. The lack of market maker intervention can create a huge spike in pps. Remember mega money was loading. Any positive feedback & $LAHO will trade much higher. GL
Creative Medical Technology Holdings to Expand into 10 Billion Dollar per Year Lower Back Pain Market with Acquisition of Issued US Stem Cell Patent
Clinical Stage Stem Cell Company Continues Aggressive Pursuit of Personalized, Rapid to Implement, Autologous Regenerative Medicine Procedures
https://www.prnewswire.com/news-releases/creative-medical-technology-holdings-to-expand-into-10-billion-dollar-per-year-lower-back-pain-market-with-acquisition-of-issued-us-stem-cell-patent-300459902.html
$CELZ
Creative Medical Technology Holdings Inc @CaverStem @femcelz @CMTH_Inc StemSpine® AmnioStemâ„¢
https://t.co/lK6lAPFMkV
Most of been the Ceo form 4 insider buyer
$LAHO will trade on the Greys. It will dip but by no means will it not recover. Infact if enough demand is still intact $LAHO can still trade up. Without market makers the price will fluctuate more than usual, however it's not over till the fat lady sings. Interesting to see how the company plans on gaining investors confidence back. If it's indeed a scam shares will be difficult to unload.
$LAHO
Help to reform Grey market structure
$LAHO
— John Guerriero (@vulken17) September 7, 2019
Help to reform Grey market structure
Voice opinions to multiple SEC source linkshttps://t.co/tdWlY17fUx
rule-comments@sec.gov
chairmanoffice@sec.gov pic.twitter.com/yPclCDa5Jx
Yup to simple it's antiquated. Much better technology to match trades out there. Im sure everyone would like to sellers & or buyers on a lit market. Not rocket science. If there is demand why stifle the market by calling orders in & hoping to get a match
I know how it works & it's very ineffective
If they care about retail then they will reform the Grey market structure & rules associated imo. Only way to get them to do so is ask. Nothing to lose but much to gain. If there is demand why not make the market more efficient for bagholders.
$LAHO
Help to reform Grey market structure
$LAHO
— John Guerriero (@vulken17) September 7, 2019
Help to reform Grey market structure
Voice opinions to multiple SEC source linkshttps://t.co/tdWlY17fUx
rule-comments@sec.gov
chairmanoffice@sec.gov pic.twitter.com/yPclCDa5Jx
$LAHO
— John Guerriero (@vulken17) September 7, 2019
Help to reform Grey market structure
Voice opinions to multiple SEC source linkshttps://t.co/tdWlY17fUx
rule-comments@sec.gov
chairmanoffice@sec.gov pic.twitter.com/yPclCDa5Jx
$LAHO
Help to reform Grey market structure
$LAHO
— John Guerriero (@vulken17) September 7, 2019
Help to reform Grey market structure
Voice opinions to multiple SEC source linkshttps://t.co/tdWlY17fUx
rule-comments@sec.gov
chairmanoffice@sec.gov pic.twitter.com/yPclCDa5Jx
$LAHO
Help to reform Grey market structure
$LAHO
— John Guerriero (@vulken17) September 7, 2019
Help to reform Grey market structure
Voice opinions to multiple SEC source linkshttps://t.co/tdWlY17fUx
rule-comments@sec.gov
chairmanoffice@sec.gov pic.twitter.com/yPclCDa5Jx
$LAHO
Help to reform Grey market structure
$LAHO
— John Guerriero (@vulken17) September 7, 2019
Help to reform Grey market structure
Voice opinions to multiple SEC source linkshttps://t.co/tdWlY17fUx
rule-comments@sec.gov
chairmanoffice@sec.gov pic.twitter.com/yPclCDa5Jx
$LAHO investors direct your concerns to the appropriate SEC department
Link below
https://www.sec.gov/contact-information/sec-directory